bovin
coronaviru
bcv
hemagglutin
encephalomyel
viru
hev
swine
found
grow
high
titer
mdck
cell
sublin
madin
darbi
canin
kidney
cell
viru
grown
cell
use
isol
purifi
heprotein
protein
shown
recent
acetylesteras
activ
function
receptordestroy
enzym
bcv
show
hev
contain
enzym
glycoprotein
solubil
treatment
virion
octylglucosid
follow
centrifug
sucros
gradient
surfac
protein
hemagglutininesteras
obtain
purifi
form
remov
deterg
dialysi
form
rosett
shown
electron
microscopi
purifi
protein
retain
acetylesteras
activ
abl
function
receptordestroy
enzym
render
red
blood
cell
resist
agglutin
coronavirus
h
e
protein
releas
viral
membran
fail
agglutin
red
blood
cell
howev
found
recogn
glycoconjug
contain
acid
indic
bind
assay
rat
serum
protein
blot
nitrocellulos
abil
inhibit
hemagglutin
activ
bcv
hev
influenza
c
viru
purifi
enzym
provid
use
tool
analyz
cellular
report
recent
bovin
coronaviru
bcv
contain
receptordestroy
enzym
vlasak
et
al
first
exampl
enzym
present
positivestrand
rna
viru
receptordestroy
enzym
known
structur
compon
negativestrand
rna
virus
influenza
virus
paramyxovirus
hirst
influenza
b
virus
well
paramyxovirus
inactiv
receptor
mean
neuraminidas
releas
termin
sialic
acid
glycoconjug
klenk
et
al
receptordestroy
enzym
influenza
c
viru
hand
cleav
glycosid
linkag
rather
ester
linkag
identifi
acetylesteras
herrler
et
abl
releas
acet
variou
synthet
substrat
vlasak
et
schauer
et
al
receptordestroy
activ
howev
due
releas
acetyl
group
posit
acid
herrler
et
al
residu
crucial
abil
influenza
c
viru
recogn
glycoprotein
receptor
herrler
et
roger
et
al
request
reprint
address
intrigu
observ
sequenc
similar
glycoprotein
hef
influenza
c
viru
protein
sequenc
deriv
open
read
frame
within
genom
mous
hepat
viru
luytj
et
led
find
bcv
type
receptordestroy
enzym
influenza
c
viru
vlasak
et
al
acetylesteras
activ
bcv
shown
function
glycoprotein
vlasak
et
al
amino
acid
sequenc
deriv
nucleotid
sequenc
clone
mrna
parker
et
al
interestingli
protein
present
coronavirus
other
avian
infecti
bronchiti
viru
porcin
transmiss
gastroenter
viru
felin
infecti
periton
viru
lack
correspond
protein
genom
contain
open
read
frame
code
protein
howev
express
infect
cell
luytj
et
al
shieh
et
al
murin
coronavirus
contain
protein
sugiyama
amano
shieh
et
al
protein
strain
mhvjhm
shown
acetylesteras
activ
pfleider
et
describ
isol
purif
bcv
porcin
hemagglutin
encephalomyel
viru
hev
activ
purifi
glycoprotein
report
schultz
et
al
strain
bcv
obtain
dr
rott
giessen
frg
strain
hev
provid
dr
hess
koblenz
frg
mdck
cell
sublin
madindarbi
canin
kidney
cell
maintain
describ
previous
herrler
et
al
growth
purif
viru
bcv
hev
grown
mdck
cell
report
recent
schultz
et
al
viru
harvest
supernat
hrp
clarif
medium
lowspe
centrifug
rpm
min
viru
sediment
ultracentrifug
rpm
hr
sw
rotor
pellet
resuspend
pb
layer
sucros
gradient
ww
pb
centrifug
sw
ti
rotor
rpm
min
viru
band
collect
dilut
pb
sediment
centrifug
condit
viru
pellet
resuspend
pb
use
analysi
polyacrylamid
gel
electrophoresi
ii
determin
esteras
activ
iii
hemagglutin
hemagglutinationinhibit
assay
iv
purif
viral
glycoprotein
purifi
coronaviru
suspend
pb
incub
presenc
noctylglucopyranosid
min
room
temperatur
centrifug
min
g
supernat
incub
min
follow
centrifug
min
rpm
tla
rotor
supernat
layer
onto
sucros
gradient
ww
cushion
ml
sucros
pb
contain
octylglucosid
centrifug
hr
rpm
rotor
fraction
ml
collect
bottom
tube
sampl
analyz
sdspolyacrylamid
gel
electrophoresi
assay
acetylesteras
activ
hemagglutin
hemagglutinationinhibit
assay
well
treatment
cell
surfac
receptor
fraction
dialyz
pbsh
enzym
activ
preserv
longer
period
purifi
acetylesteras
store
presenc
mg
bovin
serum
albumin
per
millilit
hemagglutin
assay
perform
describ
previous
herrler
et
al
hemagglutin
titer
indic
reciproc
valu
maximum
dilut
caus
complet
agglutin
hemagglutinationinhibit
assay
perform
describ
previous
herrler
et
al
esteras
activ
purifi
virion
protein
determin
incub
pnitrophenyl
acet
pnpa
ml
pb
room
temperatur
substrat
dissolv
vol
ethanol
use
kinet
program
releas
acet
monitor
determin
optic
densiti
nm
min
interv
min
background
level
substrat
incub
absenc
esteras
subtract
sampl
amount
esteras
cleav
umol
pnitrophenyl
acet
min
room
temperatur
defin
unit
enzym
label
esteras
h
dfp
perform
describ
previous
herrler
et
al
purifi
virion
protein
pb
incub
hlabel
dfp
cimmol
ice
min
sampl
prepar
electrophoresi
analysi
protein
sdspolyacrylamid
gel
electrophoresi
perform
describ
previous
herrler
et
sampl
contain
suspens
chicken
erythrocyt
incub
gradient
fraction
contain
purifi
protein
see
prior
use
acetylesteras
dialyz
remov
octylglucosid
incub
hr
red
blood
cell
wash
twice
pb
suspend
ml
buffer
erythrocyt
control
cell
incub
pb
use
determin
ha
titer
bcv
hev
influenza
c
viru
solidphas
assay
viru
bind
differ
dilut
rat
serum
pb
appli
nitrocellulos
airdri
excess
proteinbind
site
block
nonfat
dri
milk
pb
overnight
nitrocellulos
strip
wash
three
time
min
tween
incub
hr
pb
purifi
acetylesteras
influenza
c
viru
mu
n
naoh
subsequ
step
done
follow
three
wash
pb
tween
nitrocellulos
incub
hr
bcv
protein
bcv
untreat
pretreat
dfp
influenza
viru
wsn
wash
pbstween
strip
incub
rabbit
antiserum
direct
bcv
dilut
influenza
viru
dilut
nitrocellulos
wash
three
time
incub
hr
biotinyl
antirabbit
immunoglobulin
donkey
wash
strip
incub
streptavidinbiotinyl
horseradish
peroxidas
complex
hr
wash
bound
bcv
protein
wsn
detect
incub
nitrocellulos
pb
naphtol
h
neg
stain
sampl
appli
piooforrnco
copper
grid
stain
uranylacet
examin
siemenselmiskop
growth
bcv
hev
mdck
cell
mdck
cell
sublin
madindarbi
canin
kidney
cell
differ
sublin
function
morpholog
characterist
richardsonet
strain
influenza
c
viru
found
grow
high
titer
cell
line
anoth
sublinemdck
iiwa
resist
infect
lack
cell
surfac
receptor
herrler
klenk
szepanski
et
al
due
similar
erythrocyt
receptor
bcv
isol
acetylesteras
coronavirus
influenza
c
viru
tri
grow
bcv
mdck
cell
strain
bcv
grown
previous
bovin
cell
cultur
storz
rott
abl
replic
mdck
cell
without
adapt
hemagglutin
titer
hauml
determin
supernat
hr
p
growth
kinet
observ
strain
hev
grown
previous
porcin
cell
cultur
hess
bachmann
titer
equal
high
higher
report
bcv
hev
cell
line
mdckgrown
coronavirus
found
acetylesteras
activ
compar
viru
suspens
ha
titer
abil
virus
releas
acet
pnitrophenyl
acet
similar
hev
somewhat
activ
bcv
fig
expect
previou
studi
influenza
c
viru
bcv
muchmor
varki
vlasak
et
al
esteras
activ
mdckgrown
coronavirus
abolish
treatment
dfp
compound
inhibit
serin
esteras
proteas
coval
attach
activesit
serin
time
viru
harvest
cytopath
chang
detect
monolay
mdck
cell
infect
either
bcv
hev
virion
releas
medium
purifi
centrifug
sucros
gradient
analyz
sdspolyacrylamid
gel
electrophoresi
shown
fig
hev
follow
coomassi
stain
gel
major
band
visibl
known
structur
polypeptid
nucleocapsid
protein
n
membran
protein
surfac
protein
hemagglutininesteras
protein
latter
polypeptid
detect
nonreduc
condit
disulfidelink
dimer
z
sever
coronavirus
requir
two
round
gradient
centrifug
satisfi
degre
purif
use
mdck
cell
system
singl
gradient
centrifug
step
suffici
obtain
bcv
hev
purifi
form
acetylesteras
isol
coronavirus
bya
modif
procedur
use
forth
purif
influenza
c
glycoprotein
harrier
et
al
purifi
hev
bcv
treat
octylglucosid
solubil
compon
lipid
envelop
viral
polypeptid
n
sediment
centrifug
shown
glycoprotein
remain
supernat
centrifug
sucros
gradient
contain
deterg
determin
locat
viral
protein
gradient
fraction
analyz
sdspolyacrylamid
gel
electrophoresi
shown
fig
hev
peak
protein
detect
fraction
igg
found
sediment
behavior
shown
sprotein
well
separ
major
present
fraction
ident
separ
obtain
glycoprotein
bcv
compar
fig
clear
separ
coronaviru
glycoprotein
also
evid
individu
fraction
analyz
acetylesteras
activ
use
pnitrophenyl
acet
substrat
fig
peak
fraction
esteras
activ
bcv
hev
coincid
heprotein
fraction
enzymat
releas
acet
detect
fraction
purif
procedur
preserv
acetylesteras
activ
also
sensit
enzym
treatment
dfp
bind
coval
serin
hydrolas
shown
fig
upon
incub
h
dfp
purifi
becom
radioact
label
figur
also
fig
esteras
activ
sucros
gradient
fraction
centrifug
glycoprotein
bcv
circl
hev
squar
compar
fig
polypeptid
analysi
gradient
fraction
illustr
initi
treatment
viru
deterg
perform
two
step
intermitt
centrifug
first
centrifug
omit
part
mprotein
remain
supernat
gradient
centrifug
cosedi
compar
lane
e
f
order
analyz
effect
purifi
heprotein
cell
necessari
remov
octylglucosid
gradient
fraction
contain
dialyz
analyz
electron
microscopi
remov
deterg
result
rosett
format
glycoprotein
shown
fig
bcvhe
report
viral
surfac
glycoprotein
analysi
purifi
heprotein
receptorbind
receptordestroy
activ
purifi
protein
analyz
abil
function
receptordestroy
enzym
shown
tabl
incub
erythrocyt
purifi
acetylesteras
either
bcv
hev
render
cell
resist
agglutin
coronavirus
well
influenza
c
viru
hand
agglutin
influenza
viru
affect
result
indic
specif
coronaviru
esteras
sialat
preserv
purif
protein
next
analyz
whether
purifi
receptorbind
activ
shown
tabl
gradient
fraction
contain
unabl
agglutin
chicken
red
blood
cell
howev
found
low
hemagglutinationinhibit
activ
e
purifi
abl
prevent
intact
virion
bcv
hev
agglutin
erythrocyt
find
suggest
follow
purif
still
abl
attach
coronaviru
receptor
red
blood
cell
howev
interact
appear
suffici
agglutin
erythrocyt
abil
purifi
bind
contain
receptor
analyz
solidphas
bind
assay
rat
serum
known
potent
hemagglutinationinhibitor
influenza
c
viru
styk
well
bcv
hev
schultz
et
al
inhibitori
activ
rat
serum
mainli
due
al
macroglobulin
herrler
et
al
kitam
al
shown
contain
substanti
amount
z
herrler
bcv
purifi
viru
analyz
abil
bind
rat
serum
spot
nitrocellulos
filter
shown
fig
left
lane
attach
bcv
rat
serum
could
demonstr
purifi
gave
posit
result
assay
highest
concentr
rat
serum
test
compar
section
design
bcv
pretreat
dfp
howev
inactiv
esteras
activ
bind
protein
rat
serum
effici
bind
whole
viru
compar
section
design
bcv
hedfp
find
whether
attach
bcv
heprotein
mediat
z
serum
protein
blot
nitrocellulos
preincub
either
acetylesteras
sodium
hydroxid
treatment
known
releas
residu
neu
preincub
serum
protein
alkalin
ph
complet
abolish
bind
bcv
protein
attach
influenza
viru
strain
wsn
could
still
demonstr
fig
middl
lane
pretreat
serum
protein
acetylesteras
influenza
c
viru
hef
drastic
reduc
bind
bcv
dfptreat
protein
fig
right
lane
result
indic
purifi
protein
abl
recogn
receptor
determin
attach
glycoprotein
bind
howev
less
effici
bind
whole
virion
increas
inactiv
esteras
coronavirus
grow
readili
cell
natur
host
although
adapt
cell
speci
possibl
siddel
al
attempt
set
cell
cultur
system
two
hemagglutin
coronavirus
bcv
hev
turn
virus
grown
high
titer
mdck
bind
bcv
heprotein
bcv
influenza
aviru
strain
wsn
rat
serum
protein
differ
dilut
top
bottom
bind
assay
rat
serum
blot
nitrocellulos
serum
protein
incub
pb
left
lane
sodium
hydroxid
middl
lane
acetylesteras
influenza
c
viru
hef
right
lane
sampl
incub
viru
bcv
wsn
purifi
heprotein
either
untreat
design
pretreat
dfp
design
hedfp
bind
detect
enzymelink
immunoassay
use
rabbit
antiserum
direct
bcv
influenza
viru
cell
without
prior
adapt
sublin
madindarbi
canin
kidney
cell
shown
recent
sensit
infect
strain
influenza
c
viru
szepanski
et
viru
initi
infect
cultur
cell
attach
contain
receptor
area
major
determin
cell
tropism
influenza
c
viru
harrier
klenk
serv
also
receptor
determin
attach
bcv
hev
red
blood
cell
vlasak
et
al
schultz
et
remain
shown
whether
type
receptor
also
use
infect
cell
anoth
question
answer
whether
restrict
tropism
coronavirus
determin
cellular
receptor
later
stage
infecti
cycl
evid
present
indic
crucial
role
cellular
receptor
cell
tropism
viru
strain
report
use
protein
receptor
boyl
et
al
mdck
cell
provid
promis
system
analyz
initi
stage
infect
coronavirus
bcv
hev
appear
recogn
differ
receptor
cell
surfac
cell
line
also
known
polar
organ
reflect
among
characteristicsbi
polar
viru
infect
vesicular
stomat
viru
shown
viru
entri
releas
restrict
basolater
domain
plasma
membran
influenza
viru
hand
infect
mdck
cell
apic
basolater
side
wherea
bud
viru
restrict
apic
portion
plasma
membran
rodriguezboulan
sabatini
fuller
et
coronavirus
known
bud
intracellular
vesicl
tooz
interest
analyz
virus
type
matur
releas
polar
cell
amount
puriti
bcv
hev
grown
mdck
cell
suffici
attempt
isol
viral
glycoprotein
use
protocol
describ
possibl
get
complet
separ
coronaviru
protein
similar
method
use
triton
rather
octylglucosid
use
previous
purifi
glycoprotein
hev
callebaut
pensaert
triton
remov
dialysi
author
use
butanol
precipit
obtain
detergentfre
glycoprotein
prepar
way
unabl
agglutin
red
blood
cell
time
esteras
activ
well
abil
viru
recogn
receptor
determin
unknown
use
octylglucosid
deterg
obtain
purifi
form
isol
sprotein
also
subject
biochem
function
analysi
manuscript
prepar
sediment
behavior
isol
protein
similar
igg
consid
molecular
weight
monomer
glycoprotein
parker
et
dimer
structur
suggest
purifi
protein
dinner
also
detect
follow
polyacrylamid
gel
electrophoresi
nonreduc
condit
see
fig
indic
two
monom
held
togeth
disulfid
bond
howev
exclud
possibl
function
protein
embed
lipid
envelop
multimer
structur
e
g
tetram
dissoci
dimer
upon
deterg
treatment
andor
sucros
gradient
centrifug
gprotein
vesicular
stomat
viru
report
gradient
centrifug
result
dissoci
trimer
glycoprotein
monom
dom
et
al
two
function
assign
heprotein
hemagglutinin
esteras
esteras
could
detect
easili
purifi
protein
acetylesteras
activ
evid
color
test
synthet
substrat
pnpa
fig
abil
inactiv
erythrocyt
receptor
bcv
hev
influenza
cviru
tabl
hemagglutinin
function
could
demonstr
purifi
glycoprotein
howev
still
abl
recogn
z
contain
receptor
indic
bindingassay
rat
serum
protein
fig
byth
low
hemagglutinationinhibit
activ
purifi
glycoprotein
tabl
interact
howev
suffici
agglutin
erythrocyt
situat
reminisc
influenza
c
viru
purifi
glycoprotein
hef
also
esteras
hemagglutinationinhibit
hemagglutin
activ
herrler
et
al
purifi
hemagglutinin
influenza
virus
hand
shown
form
rosett
abl
agglutin
red
blood
cell
laver
valentin
failur
purifi
protein
caus
hemagglutin
due
lack
rosett
format
fig
receptordestroy
activ
counteract
receptorbind
activ
evid
result
solid
phase
bind
assay
bind
bcvhe
found
effici
inactiv
esteras
dfp
fig
bind
assay
appli
hevh
similar
protein
test
see
fig
tabl
like
result
obtain
bcvhe
also
valid
hevh
dfptreat
still
unabl
agglutin
red
blood
cell
howev
interact
erythrocyt
purifi
coronaviru
glycoprotein
erythrocyt
incub
dfptreat
pour
microtit
plate
place
semivert
posit
shown
contrast
control
cell
lack
ha
activ
purifi
protein
might
due
conform
chang
purif
procedur
affect
receptorbind
activ
receptordestroy
activ
anoth
possibl
individu
glycoprotein
low
affin
z
contain
receptor
case
multival
attach
heprotein
present
viral
membran
may
increas
bind
activ
enabl
agglutin
erythrocyt
case
purifi
acetylesteras
bcv
hev
use
analyt
tool
studi
import
z
gener
specif
cellular
receptor
coronavirus
technic
assist
birgit
doll
heldrun
grate
acknowledg
thank
dr
r
rot
r
g
hess
provid
